FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2767402673> ?p ?o ?g. }

• W2767402673 abstract "The “susceptibility gap” in a dog diagnosed with adult heartworms has been defined as the period of time in which some Dirofilaria immitis stages are not susceptible to treatment with either macrocyclic lactones or melarsomine dihydrochloride. This was previously defined within the American Heartworm Society guidelines as a period of about 3 months “as per product labels.” It can be postulated, however, that a susceptibility gap does not exist with the combination of continued macrocyclic lactone therapy coupled with a three-dose melarsomine dihydrochloride protocol where the first intramuscular treatment is near the time of first diagnosis. Melarsomine dihydrochloride was originally also investigated as a “preventive” as well as a treatment for adult heartworm infection where it would be given to dogs by intramuscular injection every 4 months; therefore, there was early interest in its ability to kill younger worms. A single intramuscular injection of 2.5 mg melarsomine dihydrochloride/kg has an efficacy of 82.1% against 4-month-old worms. When it was given to dogs with older heartworms, 7 and 12 months of age, a single injection was only 55.6% and 51.7% effective, respectively. Thiacetarsamide has been shown to be 99.7% effective against 2-month-old heartworms and other work has shown that melarsomine dihydrochloride is 100% efficacious against these younger forms. With the development and US Food and Drug Administration (FDA) approval of spinosad + milbemycin oxime (Trifexis®, Elanco), milbemycin oxime + praziquantel (Interceptor® Plus, Novartis, now Elanco), and milbemycin oxime + lufenuron + praziquantel (Sentinel® Spectrum®, Novartis, now Virbac), it was shown that repeated treatments of dogs with milbemycin oxime also has efficacy against 3-month-old heartworms. Thus, no improvement in efficacy is expected with a delay in initiating therapy with both melarsomine dihydrochloride and macrocyclic lactones, even with the presence of younger heartworms. Starting treatment at diagnosis appears to be acceptable for maximal heartworm clearance based on published data. Delaying treatment has the disadvantage of allowing disease progression and continued heartworm growth. The collective data that has been reviewed indicates that continued macrocyclic lactone administration with two additional injections of melarsomine dihydrochloride a month later will protect dogs against all heartworm stages, including those heartworms 2 months of age or younger at diagnosis, when both treatments are started upon diagnosis." @default.
• W2767402673 created "2017-11-17" @default.
• W2767402673 creator A5044710952 @default.
• W2767402673 creator A5056679891 @default.
• W2767402673 date "2017-11-01" @default.
• W2767402673 modified "2023-10-06" @default.
• W2767402673 title "Examination of the “susceptibility gap” in the treatment of canine heartworm infection" @default.
• W2767402673 cites W1449535677 @default.
• W2767402673 cites W147391520 @default.
• W2767402673 cites W1672683010 @default.
• W2767402673 cites W1982335106 @default.
• W2767402673 cites W1987101109 @default.
• W2767402673 cites W2002802632 @default.
• W2767402673 cites W2031874486 @default.
• W2767402673 cites W2076224101 @default.
• W2767402673 cites W2078069901 @default.
• W2767402673 cites W2093615671 @default.
• W2767402673 cites W2142982675 @default.
• W2767402673 cites W2151006617 @default.
• W2767402673 cites W2151108466 @default.
• W2767402673 cites W2314140018 @default.
• W2767402673 cites W2408096797 @default.
• W2767402673 cites W2409231180 @default.
• W2767402673 cites W2411383617 @default.
• W2767402673 cites W2412160822 @default.
• W2767402673 cites W2441294467 @default.
• W2767402673 cites W2531426871 @default.
• W2767402673 cites W4290135448 @default.
• W2767402673 cites W76555183 @default.
• W2767402673 cites W2413902749 @default.
• W2767402673 doi "https://doi.org/10.1186/s13071-017-2433-9" @default.
• W2767402673 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5688481" @default.
• W2767402673 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29143689" @default.
• W2767402673 hasPublicationYear "2017" @default.
• W2767402673 type Work @default.
• W2767402673 sameAs 2767402673 @default.
• W2767402673 citedByCount "15" @default.
• W2767402673 countsByYear W27674026732018 @default.
• W2767402673 countsByYear W27674026732019 @default.
• W2767402673 countsByYear W27674026732020 @default.
• W2767402673 countsByYear W27674026732021 @default.
• W2767402673 countsByYear W27674026732022 @default.
• W2767402673 countsByYear W27674026732023 @default.
• W2767402673 crossrefType "journal-article" @default.
• W2767402673 hasAuthorship W2767402673A5044710952 @default.
• W2767402673 hasAuthorship W2767402673A5056679891 @default.
• W2767402673 hasBestOaLocation W27674026731 @default.
• W2767402673 hasConcept C126322002 @default.
• W2767402673 hasConcept C165901193 @default.
• W2767402673 hasConcept C173758957 @default.
• W2767402673 hasConcept C203014093 @default.
• W2767402673 hasConcept C2776225656 @default.
• W2767402673 hasConcept C2776291583 @default.
• W2767402673 hasConcept C2776355835 @default.
• W2767402673 hasConcept C2776444496 @default.
• W2767402673 hasConcept C2777097416 @default.
• W2767402673 hasConcept C2779744950 @default.
• W2767402673 hasConcept C42972112 @default.
• W2767402673 hasConcept C59822182 @default.
• W2767402673 hasConcept C71924100 @default.
• W2767402673 hasConcept C86803240 @default.
• W2767402673 hasConcept C98274493 @default.
• W2767402673 hasConceptScore W2767402673C126322002 @default.
• W2767402673 hasConceptScore W2767402673C165901193 @default.
• W2767402673 hasConceptScore W2767402673C173758957 @default.
• W2767402673 hasConceptScore W2767402673C203014093 @default.
• W2767402673 hasConceptScore W2767402673C2776225656 @default.
• W2767402673 hasConceptScore W2767402673C2776291583 @default.
• W2767402673 hasConceptScore W2767402673C2776355835 @default.
• W2767402673 hasConceptScore W2767402673C2776444496 @default.
• W2767402673 hasConceptScore W2767402673C2777097416 @default.
• W2767402673 hasConceptScore W2767402673C2779744950 @default.
• W2767402673 hasConceptScore W2767402673C42972112 @default.
• W2767402673 hasConceptScore W2767402673C59822182 @default.
• W2767402673 hasConceptScore W2767402673C71924100 @default.
• W2767402673 hasConceptScore W2767402673C86803240 @default.
• W2767402673 hasConceptScore W2767402673C98274493 @default.
• W2767402673 hasIssue "S2" @default.
• W2767402673 hasLocation W27674026731 @default.
• W2767402673 hasLocation W27674026732 @default.
• W2767402673 hasLocation W27674026733 @default.
• W2767402673 hasLocation W27674026734 @default.
• W2767402673 hasOpenAccess W2767402673 @default.
• W2767402673 hasPrimaryLocation W27674026731 @default.
• W2767402673 hasRelatedWork W1473068704 @default.
• W2767402673 hasRelatedWork W1968257504 @default.
• W2767402673 hasRelatedWork W2062027981 @default.
• W2767402673 hasRelatedWork W2171511089 @default.
• W2767402673 hasRelatedWork W2326321057 @default.
• W2767402673 hasRelatedWork W2523506607 @default.
• W2767402673 hasRelatedWork W2767402673 @default.
• W2767402673 hasRelatedWork W2989794391 @default.
• W2767402673 hasRelatedWork W328264856 @default.
• W2767402673 hasRelatedWork W4383374849 @default.
• W2767402673 hasVolume "10" @default.
• W2767402673 isParatext "false" @default.
• W2767402673 isRetracted "false" @default.
• W2767402673 magId "2767402673" @default.
• W2767402673 workType "article" @default.